These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21954520)

  • 1. Rational use of anti-ulcer drugs to prevent serious gastroduodenal adverse effects associated with NSAIDS.
    Prescrire Int; 2011 Sep; 20(119):219. PubMed ID: 21954520
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with high risk of gastrointestinal bleeding requiring nonsteroidal anti-inflammatory drugs.
    Wilcox CM; Ladabaum U
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1090-3. PubMed ID: 16890026
    [No Abstract]   [Full Text] [Related]  

  • 4. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misoprostol and NSAID.
    Weinstein WM
    J Clin Gastroenterol; 1991 Feb; 13(1):117. PubMed ID: 1901074
    [No Abstract]   [Full Text] [Related]  

  • 6. Upper gastrointestinal toxicity of rofecoxib and naproxen.
    Delgado Fernández M; Zambrana García JL; Diez García F
    N Engl J Med; 2001 May; 344(18):1398; author reply 1398-9. PubMed ID: 11336056
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB; Pipalia DH; Naik SR; Tilve GH
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract]   [Full Text] [Related]  

  • 8. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of upper gastrointestinal problems in patients taking NSAIDs.
    Prichard P
    Aust Fam Physician; 1991 Dec; 20(12):1739-41. PubMed ID: 1687198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
    Fujikawa Y; Watanabe T; Tominaga K; Fujiwara Y; Sato H; Arakawa T
    Nihon Rinsho; 2011 Jun; 69(6):1039-43. PubMed ID: 21688624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol vs omeprazole for ulcers associated with NSAIDs.
    Bell AD
    Can Fam Physician; 1998 Nov; 44():2371-2. PubMed ID: 9839045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention and therapy of NSAID-induced ulcers: fact versus myth].
    Fried M; Bertschinger P
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1569-72. PubMed ID: 8927961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDs, misoprostol, and gastrointestinal bleeding.
    Shield MJ
    Lancet; 1991 May; 337(8751):1221-2. PubMed ID: 1673756
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs].
    Bar-Dayan Y; Levi Y
    Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL; Stock KP; Hüdepohl M
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric safety and enteric-coated aspirin.
    Guslandi M
    Lancet; 1997 Feb; 349(9049):431. PubMed ID: 9033490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
    Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP
    Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.